Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2

Interventions

pembrolizumab 133Carboplatin 132Cisplatin 121Paclitaxel 105Gemcitabine 91Specimen Handling 82Magnetic Resonance Spectroscopy 82Docetaxel 74Dexamethasone 62Cyclophosphamide 60Pemetrexed 58Capecitabine 56Bevacizumab 56durvalumab 54Oxaliplatin 51Radiotherapy 50Doxorubicin 50Fluorouracil 49Radiation 46Leucovorin 44Rituximab 43Lenalidomide 42Vincristine 40Etoposide 38Nivolumab 37atezolizumab 36Letrozole 35130-nm albumin-bound paclitaxel 33Irinotecan 31Prednisone 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Vindesine × 90 days × Clear all
NCT04043494 2026-05-06

LBL 2018

University Hospital Muenster

Phase 3 Recruiting
683 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02845882 2026-03-18

LBL-2016 for Children or Adolescents in China

Children's Cancer Group, China

Phase 3 Active not recruiting
150 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡